The effects of (+)-SKF10047 and ketamine hydrochloride on stereotyped behaviour, locomotor activity and ataxia in guinea pig

European Journal of Pharmacology

Volumn 307, Issue 3, 1996, Pages 269-273

  Jerram, Annabelle H ^a   Smith, Paul F ^b   Darlington, Cynthia L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

(+) SKF10047; Guinea pig; Ketamine hydrochloride; Receptor

Indexed keywords

KETAMINE; N ALLYLNORMETAZOCINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATAXIA; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RIGHTING REFLEX; STEREOTYPY;

EID: 0030568710     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00267-1     Document Type: Article

References (25)

1. Boyce, S., N.M.J. Rupniak, M.J. Steventon, G. Cook and S.D. Iversen, 1991, Psychomotor activity and cognitive disruption attributable to NMDA, but not to sigma, interactions in primates, Behav. Brain Res. 42, 115.
2. Brady, K.T., R.L. Balster and E.L. May, 1982, Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats, Science 215, 178.
3. Carter, A.J., 1994, Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination, J. Pharmacol. Exp. Ther. 269, 573.
4. Chavkin, C., 1990, The sigma enigma: biochemical and functional correlates emerge for the haloperidol-sensitive sigma binding site, Trends Pharmacol. Sci. 11, 213.
5. Contreras, P.C., K.C. Rice, A.E. Jacobson and T.L. O'Donohue, 1986, Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions, Eur. J. Pharmacol. 121, 9.
6. Contreras, P.C., M.L. Contreras, T.L. O'Donohue and C.C. Lair, 1988. Biochemical and behavioral effects of sigma and PCP ligands. Synapse 2, 240.
7. Dingwall, B., B. Reeve, M. Hutchinson, P.F. Smith and C.L. Darlington, 1993, The tolerometer: a fast, automated method for the measurement of righting reflex latency in chronic drug studies, J. Neurosci. Methods 48, 111.
8. Ellison, G., 1995, The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res. Rev. 20, 250.
9. Hargreaves, E.L. and D.P. Cain, 1995, MK801-induced hyperactivity: duration of effects in rats, Pharmacol. Biochem. Behav. 51, 13.
10. Hiramatsu, M., T. Nabeshima, H. Furukawa and T. Kameyama, 1993, Different effects of ethylketocyclazocine on phencyclidine-and N-allylnormetazocine-induced stereotyped behaviors in rats. Pharmacol. Biochem. Behav. 28, 489.
11. Hiramatsu, M., A.K. Cho and T. Nabeshima, 1989, Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine, Eur. J. Pharmacol. 166, 359.
12. Javitt, D.C. and S.R. Zukin, 1991, Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatr. 148, 1301.
13. Jerram, A.H., P.F. Smith and C.L. Darlington, 1996, A dose-response analysis of the behavioral effects of (+)MK-801 in guinea pig: comparison with CPP, Pharmacol. Biochem. Behav.
14. Jones, K.W., L.M. Bauerle and V.J. DeNoble, 1990, Differential effects of sigma and phencyclidine receptor ligands on learning, Eur. J. Pharmacol. 179, 97.
15. Lahti, A.C., H.H. Holcomb, D.R. Medoff and C.A. Tamminga, 1995, Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 6, 869.
16. Lodge, D. and K.M. Johnson, 1990, Noncompetitive excitatory amino acid receptor antagonists, Trends Pharmacol. Sci. 11, 81.
17. Marquis, K.L., N.C. Paquette, R.P. Gussio and J.E. Moreton, 1989, Comparative electroencephalographic and behavioral effects of phencyclidine. (+)-SKF-10,047 and MK-801 in rats, J. Pharmacol. Exp. Therap. 251, 1104.
18. McBain, C.J. and M.L. Mayer, 1994, N-methyl-D-aspartic acid σ receptor structure and function, Physiol. Rev. 74, 723.
19. 3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 188, 211.
20. Olney, J.W., J. Labruyere and M.T. Price, 1989, Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science 244, 1360.
21. Sanger, D.J. and A. Jackson, 1989, Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats, J. Pharmacol. Exp. Ther. 248, 1215.
22. Snedecor, G.W. and W.G. Cochran, 1989, Statistical Methods, 8th edn. (Iowa State University Press, Ames, IA).
23. Sturgeon, R.D., R.G. Fessler and H.Y. Meltzer, 1979, Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats, Eur. J. Pharmacol. 59, 169.
24. Vaupel, D.B., 1983, Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog, Eur. J. Pharmacol. 92, 269.
25. 3H]phencyclidine binding in rat central nervous system, Proc. Natl. Acad. Sci. USA 76, 5372.